EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
about
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary studyIntraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic massesPercutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaHysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancerIntra-operative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic massesHysterectomy for patients with locally advanced cervical cancer after primary radiotherapy and/or chemotherapyScreening for oesophageal cancerPercutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaScreening for oesophageal cancerThe changing global patterns of female breast cancer incidence and mortalityMunicipal distribution of bladder cancer mortality in Spain: possible role of mining and industryInfection with the carcinogenic human liver fluke, Opisthorchis viverriniOverweight, obesity and risk of liver cancer: a meta-analysis of cohort studiesEliciting symptoms interpreted as normal by patients with early-stage lung cancer: could GP elicitation of normalised symptoms reduce delay in diagnosis? Cross-sectional interview study.The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry.Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).Age-specific cancer survival in Estonia: recent trends and data quality.Municipal mortality due to thyroid cancer in Spain.Socio-economic status and overall and cause-specific mortality in SwedenEvidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data.Improvements in undergraduate oncology education introduced at Polish medical universities between 2004 and 2010 under Poland's "National Program for Combating Neoplastic Diseases".ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.Modelling population-based cancer survival trends using join point models for grouped survival data.Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline.Developing the atlas of cancer in Queensland: methodological issues.Cancer survival and excess mortality estimates among adolescents and young adults in Western Australia, 1982-2004: a population-based studySerum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot studyA generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer.Control of advanced cancer: the road to chronicity.Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy.Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer.Sex differences in cancer survival in Estonia: a population-based studySurvival of prostate cancer patients in central and northern Denmark, 1998-2009Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthaseBreast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001.Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progressionThe Global Burden of Cancer 2013Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10Impact of mental health problems on case fatality in male cancer patients.Development and validation of a classification and scoring system for the diagnosis of oral squamous cell carcinomas through confocal laser endomicroscopy
P2860
Q21260394-1E3B3D6A-E6DE-437B-B421-92802B3BF638Q24185990-A6478E05-635A-4309-8C0E-AC7BA40CD5A9Q24186496-613297CC-D5AF-427F-9AA3-D76C5E363242Q24186602-A3C51591-46F8-4845-9380-B581F4633759Q24201044-A3F33848-3675-4E04-BEC3-92E1D05A4570Q24201858-C8F23FB0-D282-4CAF-A966-3EEC755A2B1FQ24202341-83F43F6B-B16F-4832-8903-0C0C9E0D2BA9Q24240216-9F22FDF7-D1CE-4CAE-916E-AC0062A9CAB0Q24240616-28B2B353-C1F8-443C-A740-E2FEBBEE10A9Q24795947-A12A3CB3-CBAB-4868-9B9C-4A274CE52C82Q25256887-3C329A49-F0D1-490A-8476-0925E5ED2AFAQ27692556-65E396ED-0696-455C-930B-63B50F4E56D0Q28219510-A74E89C5-61F7-4895-860C-0DE3249DD568Q30530822-E15FA305-9240-42B7-AD3F-FDBF1D405E1DQ30659496-CBE41A9F-0474-489A-ADC1-5FD863771692Q30873972-653F8B0D-7C43-4113-BAFC-8B59A00D2650Q30985736-AE6B6145-A3D7-4E32-97A8-D060457520E3Q33266827-1D8135BC-54FD-49BE-9114-4E209C2BA939Q33372915-65A737D6-32B0-4474-A28C-A2BD826385B3Q33928596-00D85312-A44E-4285-BEEF-0CAB3168BE32Q34030133-DA2BB510-9D81-4358-B536-C5742EC5E7DCQ34084892-DE524C4F-8E1A-46AC-8684-0ABA14FFBC21Q34115306-2F02ACD2-D003-494B-B90F-C91B3524667FQ34325697-5C85C77F-25B4-4823-B9B7-611EE6A058CEQ34576476-0B219FCF-3D5A-44F8-8371-D70267D0CFDBQ34584383-7B38D700-067F-4A49-82F3-53AC054894E2Q34584928-CB9849D8-D551-471E-8CC2-7E5BF34DEAEEQ34733919-8B75B467-A51A-4672-84C2-042477828F21Q34874471-2008D156-6567-4E55-BC3A-2C285897EF95Q35024629-EF9319C0-C675-4C87-9D04-88D5073A9D27Q35071734-92886E21-0693-4E0D-9211-FDDD93DD64BCQ35108674-8C9ACAE3-349B-415D-9206-C1DDA97F1454Q35131254-75F9694F-A308-4A9C-A692-34D97CBC8262Q35161704-050CDFD1-021A-4CED-8B40-324683F18D85Q35233475-6BB3BEA0-4736-4DAF-86A2-DB48015F8C8CQ35421768-5D7887FF-BCFC-4609-9531-5B974522A905Q35847426-42708BE5-16FA-4C18-BE34-023A046DE2E1Q35944238-75D311C1-A35D-42AA-A8B1-5AD55682AE46Q35998488-80CB7186-7BF4-4BE8-BA0B-2FF3114D1ABFQ36038839-471DF2D6-17A8-4ED2-B138-2491E162B19D
P2860
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
@en
type
label
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
@en
prefLabel
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
@en
P2093
P50
P356
P1433
P1476
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
@en
P2093
A Verdecchia
C Allemani
EUROCARE Working Group
L Ciccolallo
P304
P356
10.1093/ANNONC/MDG756
P478
14 Suppl 5
P577
2003-01-01T00:00:00Z